Department of Surgery, Boston Children's Hospital, Boston, Mass.
Division of Nephrology, Boston Children's Hospital, Boston, Mass.
J Vasc Surg. 2021 Jul;74(1):79-89.e2. doi: 10.1016/j.jvs.2020.12.053. Epub 2020 Dec 16.
To evaluate the outcomes of various surgical approaches in the treatment of renovascular hypertension and midaortic syndrome (MAS) in children.
We performed a retrospective medical record review of patients who had undergone surgery for renovascular hypertension from 2010 to 2018 at our center under the care of a multidisciplinary team. The operative interventions included mesenteric artery growth improves circulation (MAGIC), tissue expander-stimulated lengthening of arteries (TESLA), aortic bypass using polytetrafluorethylene, renal artery reimplantation, and autotransplantation. The MAGIC procedure uses the meandering mesenteric artery as a free conduit for aortic bypass. The TESLA procedure is based on lengthening the normal distal aorta and iliac arteries by gradual filling of a retroaortic tissue expander for several weeks, followed by resection of the stenotic aorta and subsequent primary reconstruction.
A total of 39 patients were identified, 10 with isolated renal artery stenosis, 26 with MAS, and 3 with systemic inflammatory vasculitis. The median age at presentation and surgery was 6.4 years (range, 0-16.3 years) and 9.3 years (range, 0-9.2 years), respectively. The MAS-associated syndromes included neurofibromatosis type 1 (15.4%) and Williams syndrome (5.1%), although most cases were idiopathic. At surgery, 33.3% had had stage 1 hypertension (HTN), 53.8% stage 2 HTN, and 12.8% normal blood pressure with a median of three antihypertensive medications. Follow-up of 37 patients at a median of 2.5 years demonstrated normal blood pressure in 86.1%, stage 1 HTN in 8.3%, and stage 2 HTN in 5.6%, with a median of one antihypertensive medication for the entire cohort.
The patterns of vascular involvement leading to renovascular hypertension in children are variable and complex, requiring thoughtful multidisciplinary planning and surgical decision-making. The MAGIC and TESLA procedures provide feasible approaches for aortic bypass and reconstruction using autologous tissues and will result in normalization of blood pressure in 85% of children 2.5 years after surgery.
评估各种手术方法在儿童肾血管性高血压和中主动脉综合征(MAS)治疗中的疗效。
我们对 2010 年至 2018 年期间在我们中心由多学科团队治疗的接受手术治疗肾血管性高血压的患者进行了回顾性病历回顾。手术干预包括肠系膜动脉生长改善循环术(MAGIC)、组织扩张器刺激动脉延长术(TESLA)、使用聚四氟乙烯进行主动脉旁路手术、肾动脉再植术和自体移植术。MAGIC 手术采用蜿蜒的肠系膜动脉作为主动脉旁路的游离移植物。TESLA 手术基于通过在主动脉后组织扩张器中逐渐填充数周来延长正常的远端主动脉和髂动脉,然后切除狭窄的主动脉并随后进行原发性重建。
共确定 39 例患者,其中 10 例为孤立性肾动脉狭窄,26 例为 MAS,3 例为全身炎症性血管炎。就诊和手术时的中位年龄分别为 6.4 岁(范围 0-16.3 岁)和 9.3 岁(范围 0-9.2 岁)。MAS 相关综合征包括神经纤维瘤病 1 型(15.4%)和威廉姆斯综合征(5.1%),尽管大多数病例为特发性。手术时,33.3%的患者为 1 期高血压(HTN),53.8%为 2 期 HTN,12.8%为正常血压,中位使用 3 种降压药物。对 37 例患者的中位随访 2.5 年显示,86.1%的患者血压正常,8.3%的患者为 1 期 HTN,5.6%的患者为 2 期 HTN,整个队列的中位降压药物为 1 种。
导致儿童肾血管性高血压的血管受累模式多种多样且复杂,需要深思熟虑的多学科规划和手术决策。MAGIC 和 TESLA 手术提供了使用自体组织进行主动脉旁路和重建的可行方法,85%的儿童在手术后 2.5 年内血压将恢复正常。